Financhill
Sell
32

QDEL Quote, Financials, Valuation and Earnings

Last price:
$30.20
Seasonality move :
3.49%
Day range:
$29.62 - $30.32
52-week range:
$23.77 - $49.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.73x
P/B ratio:
0.67x
Volume:
1.4M
Avg. volume:
1.5M
1-year change:
-5.82%
Market cap:
$2B
Revenue:
$2.8B
EPS (TTM):
-$4.97

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
QDEL
QuidelOrtho
$611.9M $0.01 -3.87% 480.41% $47.14
CATX
Perspective Therapeutics
$170.4K -$0.29 -- -55.87% $14.1071
ITGR
Integer Holdings
$464.4M $1.55 6.46% 76.23% $148.75
VNRX
VolitionRX
$375.7K -$0.05 6.24% -40.63% $2.93
VTAK
Catheter Precision
$310K -$0.20 118.75% -11.57% --
XTNT
Xtant Medical Holdings
$31.4M -$0.02 4.73% -33.33% $1.75
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
QDEL
QuidelOrtho
$29.79 $47.14 $2B -- $0.00 0% 0.73x
CATX
Perspective Therapeutics
$3.2800 $14.1071 $243.5M -- $0.00 0% 23.12x
ITGR
Integer Holdings
$121.29 $148.75 $4.2B 57.48x $0.00 0% 2.45x
VNRX
VolitionRX
$0.77 $2.93 $79.1M -- $0.00 0% 52.93x
VTAK
Catheter Precision
$0.23 -- $2.6M 0.40x $0.00 0% 2.67x
XTNT
Xtant Medical Holdings
$0.72 $1.75 $99.6M -- $0.00 0% 0.80x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
QDEL
QuidelOrtho
45.48% 1.605 105.97% 0.54x
CATX
Perspective Therapeutics
-- 1.363 -- --
ITGR
Integer Holdings
43.46% 1.032 30% 1.99x
VNRX
VolitionRX
-29.91% 3.387 11.38% 0.34x
VTAK
Catheter Precision
17.75% -1.532 53.57% 0.13x
XTNT
Xtant Medical Holdings
43.24% 1.491 51.14% 0.96x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
QDEL
QuidelOrtho
$343.3M $48.7M -6.37% -11.46% 4.84% $9.4M
CATX
Perspective Therapeutics
-- -$21.8M -- -- -- -$26.2M
ITGR
Integer Holdings
$120.3M $55.8M 2.85% 4.85% -0.02% $6.1M
VNRX
VolitionRX
-- -$5.4M -- -- -2183.56% -$4.3M
VTAK
Catheter Precision
$132K -$3.5M -126.5% -137.84% -3300.7% -$2.3M
XTNT
Xtant Medical Holdings
$20.2M $1.1M -15.44% -26.62% 3.28% $87K

QuidelOrtho vs. Competitors

  • Which has Higher Returns QDEL or CATX?

    Perspective Therapeutics has a net margin of -1.83% compared to QuidelOrtho's net margin of --. QuidelOrtho's return on equity of -11.46% beat Perspective Therapeutics's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    QDEL
    QuidelOrtho
    49.55% -$0.19 $5.5B
    CATX
    Perspective Therapeutics
    -- -$0.25 --
  • What do Analysts Say About QDEL or CATX?

    QuidelOrtho has a consensus price target of $47.14, signalling upside risk potential of 58.25%. On the other hand Perspective Therapeutics has an analysts' consensus of $14.1071 which suggests that it could grow by 330.1%. Given that Perspective Therapeutics has higher upside potential than QuidelOrtho, analysts believe Perspective Therapeutics is more attractive than QuidelOrtho.

    Company Buy Ratings Hold Ratings Sell Ratings
    QDEL
    QuidelOrtho
    3 2 0
    CATX
    Perspective Therapeutics
    10 1 0
  • Is QDEL or CATX More Risky?

    QuidelOrtho has a beta of 0.070, which suggesting that the stock is 92.959% less volatile than S&P 500. In comparison Perspective Therapeutics has a beta of 1.177, suggesting its more volatile than the S&P 500 by 17.701%.

  • Which is a Better Dividend Stock QDEL or CATX?

    QuidelOrtho has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Perspective Therapeutics offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho pays -- of its earnings as a dividend. Perspective Therapeutics pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QDEL or CATX?

    QuidelOrtho quarterly revenues are $692.8M, which are larger than Perspective Therapeutics quarterly revenues of --. QuidelOrtho's net income of -$12.7M is higher than Perspective Therapeutics's net income of -$18.2M. Notably, QuidelOrtho's price-to-earnings ratio is -- while Perspective Therapeutics's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho is 0.73x versus 23.12x for Perspective Therapeutics. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QDEL
    QuidelOrtho
    0.73x -- $692.8M -$12.7M
    CATX
    Perspective Therapeutics
    23.12x -- -- -$18.2M
  • Which has Higher Returns QDEL or ITGR?

    Integer Holdings has a net margin of -1.83% compared to QuidelOrtho's net margin of -5.14%. QuidelOrtho's return on equity of -11.46% beat Integer Holdings's return on equity of 4.85%.

    Company Gross Margin Earnings Per Share Invested Capital
    QDEL
    QuidelOrtho
    49.55% -$0.19 $5.5B
    ITGR
    Integer Holdings
    27.51% -$0.66 $2.8B
  • What do Analysts Say About QDEL or ITGR?

    QuidelOrtho has a consensus price target of $47.14, signalling upside risk potential of 58.25%. On the other hand Integer Holdings has an analysts' consensus of $148.75 which suggests that it could grow by 22.64%. Given that QuidelOrtho has higher upside potential than Integer Holdings, analysts believe QuidelOrtho is more attractive than Integer Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    QDEL
    QuidelOrtho
    3 2 0
    ITGR
    Integer Holdings
    7 1 0
  • Is QDEL or ITGR More Risky?

    QuidelOrtho has a beta of 0.070, which suggesting that the stock is 92.959% less volatile than S&P 500. In comparison Integer Holdings has a beta of 0.980, suggesting its less volatile than the S&P 500 by 1.988%.

  • Which is a Better Dividend Stock QDEL or ITGR?

    QuidelOrtho has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Integer Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho pays -- of its earnings as a dividend. Integer Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QDEL or ITGR?

    QuidelOrtho quarterly revenues are $692.8M, which are larger than Integer Holdings quarterly revenues of $437.4M. QuidelOrtho's net income of -$12.7M is higher than Integer Holdings's net income of -$22.5M. Notably, QuidelOrtho's price-to-earnings ratio is -- while Integer Holdings's PE ratio is 57.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho is 0.73x versus 2.45x for Integer Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QDEL
    QuidelOrtho
    0.73x -- $692.8M -$12.7M
    ITGR
    Integer Holdings
    2.45x 57.48x $437.4M -$22.5M
  • Which has Higher Returns QDEL or VNRX?

    VolitionRX has a net margin of -1.83% compared to QuidelOrtho's net margin of -2201.34%. QuidelOrtho's return on equity of -11.46% beat VolitionRX's return on equity of --.

    Company Gross Margin Earnings Per Share Invested Capital
    QDEL
    QuidelOrtho
    49.55% -$0.19 $5.5B
    VNRX
    VolitionRX
    -- -$0.06 -$22.6M
  • What do Analysts Say About QDEL or VNRX?

    QuidelOrtho has a consensus price target of $47.14, signalling upside risk potential of 58.25%. On the other hand VolitionRX has an analysts' consensus of $2.93 which suggests that it could grow by 282.86%. Given that VolitionRX has higher upside potential than QuidelOrtho, analysts believe VolitionRX is more attractive than QuidelOrtho.

    Company Buy Ratings Hold Ratings Sell Ratings
    QDEL
    QuidelOrtho
    3 2 0
    VNRX
    VolitionRX
    2 1 0
  • Is QDEL or VNRX More Risky?

    QuidelOrtho has a beta of 0.070, which suggesting that the stock is 92.959% less volatile than S&P 500. In comparison VolitionRX has a beta of 1.198, suggesting its more volatile than the S&P 500 by 19.798%.

  • Which is a Better Dividend Stock QDEL or VNRX?

    QuidelOrtho has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. VolitionRX offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho pays -- of its earnings as a dividend. VolitionRX pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QDEL or VNRX?

    QuidelOrtho quarterly revenues are $692.8M, which are larger than VolitionRX quarterly revenues of $246.4K. QuidelOrtho's net income of -$12.7M is lower than VolitionRX's net income of -$5.4M. Notably, QuidelOrtho's price-to-earnings ratio is -- while VolitionRX's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho is 0.73x versus 52.93x for VolitionRX. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QDEL
    QuidelOrtho
    0.73x -- $692.8M -$12.7M
    VNRX
    VolitionRX
    52.93x -- $246.4K -$5.4M
  • Which has Higher Returns QDEL or VTAK?

    Catheter Precision has a net margin of -1.83% compared to QuidelOrtho's net margin of -2828.67%. QuidelOrtho's return on equity of -11.46% beat Catheter Precision's return on equity of -137.84%.

    Company Gross Margin Earnings Per Share Invested Capital
    QDEL
    QuidelOrtho
    49.55% -$0.19 $5.5B
    VTAK
    Catheter Precision
    92.31% -$0.36 $9.6M
  • What do Analysts Say About QDEL or VTAK?

    QuidelOrtho has a consensus price target of $47.14, signalling upside risk potential of 58.25%. On the other hand Catheter Precision has an analysts' consensus of -- which suggests that it could grow by 761.7%. Given that Catheter Precision has higher upside potential than QuidelOrtho, analysts believe Catheter Precision is more attractive than QuidelOrtho.

    Company Buy Ratings Hold Ratings Sell Ratings
    QDEL
    QuidelOrtho
    3 2 0
    VTAK
    Catheter Precision
    0 0 0
  • Is QDEL or VTAK More Risky?

    QuidelOrtho has a beta of 0.070, which suggesting that the stock is 92.959% less volatile than S&P 500. In comparison Catheter Precision has a beta of -0.724, suggesting its less volatile than the S&P 500 by 172.434%.

  • Which is a Better Dividend Stock QDEL or VTAK?

    QuidelOrtho has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Catheter Precision offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho pays -- of its earnings as a dividend. Catheter Precision pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QDEL or VTAK?

    QuidelOrtho quarterly revenues are $692.8M, which are larger than Catheter Precision quarterly revenues of $143K. QuidelOrtho's net income of -$12.7M is lower than Catheter Precision's net income of -$4M. Notably, QuidelOrtho's price-to-earnings ratio is -- while Catheter Precision's PE ratio is 0.40x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho is 0.73x versus 2.67x for Catheter Precision. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QDEL
    QuidelOrtho
    0.73x -- $692.8M -$12.7M
    VTAK
    Catheter Precision
    2.67x 0.40x $143K -$4M
  • Which has Higher Returns QDEL or XTNT?

    Xtant Medical Holdings has a net margin of -1.83% compared to QuidelOrtho's net margin of 0.18%. QuidelOrtho's return on equity of -11.46% beat Xtant Medical Holdings's return on equity of -26.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    QDEL
    QuidelOrtho
    49.55% -$0.19 $5.5B
    XTNT
    Xtant Medical Holdings
    61.52% -- $77.3M
  • What do Analysts Say About QDEL or XTNT?

    QuidelOrtho has a consensus price target of $47.14, signalling upside risk potential of 58.25%. On the other hand Xtant Medical Holdings has an analysts' consensus of $1.75 which suggests that it could grow by 144.76%. Given that Xtant Medical Holdings has higher upside potential than QuidelOrtho, analysts believe Xtant Medical Holdings is more attractive than QuidelOrtho.

    Company Buy Ratings Hold Ratings Sell Ratings
    QDEL
    QuidelOrtho
    3 2 0
    XTNT
    Xtant Medical Holdings
    2 0 0
  • Is QDEL or XTNT More Risky?

    QuidelOrtho has a beta of 0.070, which suggesting that the stock is 92.959% less volatile than S&P 500. In comparison Xtant Medical Holdings has a beta of -0.139, suggesting its less volatile than the S&P 500 by 113.918%.

  • Which is a Better Dividend Stock QDEL or XTNT?

    QuidelOrtho has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Xtant Medical Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. QuidelOrtho pays -- of its earnings as a dividend. Xtant Medical Holdings pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios QDEL or XTNT?

    QuidelOrtho quarterly revenues are $692.8M, which are larger than Xtant Medical Holdings quarterly revenues of $32.9M. QuidelOrtho's net income of -$12.7M is lower than Xtant Medical Holdings's net income of $58K. Notably, QuidelOrtho's price-to-earnings ratio is -- while Xtant Medical Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for QuidelOrtho is 0.73x versus 0.80x for Xtant Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    QDEL
    QuidelOrtho
    0.73x -- $692.8M -$12.7M
    XTNT
    Xtant Medical Holdings
    0.80x -- $32.9M $58K

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Why Is Goldman Sachs Stock Up So Much?
Why Is Goldman Sachs Stock Up So Much?

Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…

Stock Ideas

Buy
60
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 52x

Buy
62
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Buy
65
AEVA alert for Jul 3

Aeva Technologies [AEVA] is up 7.78% over the past day.

Sell
44
PRGS alert for Jul 2

Progress Software [PRGS] is down 2.94% over the past day.

Sell
46
NAIL alert for Jul 3

Direxion Daily Homebuilders & Supplies Bull 3X Shs [NAIL] is up 3.1% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock